Consort Medical plc (CSRT.L) (LON:CSRT) Trading Up 0.5% – Here’s Why

Consort Medical plc (CSRT.L) (LON:CSRT)’s stock price traded up 0.5% during mid-day trading on Thursday . The company traded as high as GBX 1,010 ($12.75) and last traded at GBX 1,010 ($12.75). 768 shares changed hands during mid-day trading, a decline of 100% from the average session volume of 520,697 shares. The stock had previously closed at GBX 1,005 ($12.68).

Consort Medical plc (CSRT.L) Stock Up 0.5 %

The company has a quick ratio of 1.16, a current ratio of 1.83 and a debt-to-equity ratio of 55.58. The stock has a 50-day simple moving average of GBX 1,010 and a 200-day simple moving average of GBX 1,010. The firm has a market capitalization of £504.60 million and a PE ratio of 127.85.

Consort Medical plc (CSRT.L) Company Profile

Consort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products.